customer.service@microbix.com 
+1-905-361-8910 +1-800-794-6694 (Toll Free)
Microbix QAPs to Support Molecular & Antigen Test Platforms for Multiple Diseases MISSISSAUGA, CANADA, August 10, 2022 – Microbix...
Microbix Executes Substantial QAPs Supply Agreement
read more
NEWS RELEASES
Microbix Presenting STI Multiplex Test Controls at AACC
Quality Control Materials for Genital Ulcer Disease Molecular Assays MISSISSAUGA, CANADA, July 26, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Presenting Test Validation Methods at AACC
Usage of QAPs to Validate Whole Workflow Quality Control of Testing MISSISSAUGA, CANADA, June 3, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Reports Record Results for Q2 Fiscal 2022
Record Q2 Sales of $4.9 million, Q2 Net Earnings of $0.7 million MISSISSAUGA, May 12, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Microbix Presenting Omicron Test Control Results at CVS
QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant MISSISSAUGA, CANADA, April 29, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Presenting at the 2022 Bloom Burton Conference
Healthcare Investor Conference in Toronto on May 2 & 3, 2022 MISSISSAUGA, CANADA, April 28, 2022 – Microbix Biosystems Inc. (TSX: MBX,...
Microbix Presenting Respiratory Virus Controls Data at Two Events
QAPs Supporting Tests That Simultaneously Detect Multiple Respiratory Viruses MISSISSAUGA, CANADA, April 19, 2022 – Microbix Biosystems...
Microbix Presenting HPV Product Results at EUROGIN
QAPs Supporting Screening-Tests for High-Risk Human Papilloma Viruses MISSISSAUGA, CANADA, April 8, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Announces Annual and Special Meeting Voting Results
Microbix Announces Annual and Special Meeting Voting Results MISSISSAUGA, CANADA, March 31, 2022 - Microbix Biosystems Inc. (TSX: MBX,...
Microbix Invests to Further Scale Its Business
Implementing MasterControl® and NetSuite® Solutions to Enable Rapid Growth MISSISSAUGA, CANADA, March 29, 2022 – Microbix Biosystems Inc....
Microbix Announces Issuance of Stock Options
Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, CANADA, February 24, 2022 - Microbix Biosystems Inc. (TSX: MBX,...
Microbix Announces Nomination to Board of Directors
For Appointment of Jennifer Stewart, Accomplished Business Leader MISSISSAUGA, CANADA, February 22, 2022 – Microbix Biosystems Inc. (TSX:...
